** = Publikationen gelistet in SCI/SSCI/Pubmed
** Galhuber, M; Michenthaler, H; Heininger, C; Reinisch, I; Nössing, C; Krstic, J; Kupper, N; Moyschewitz, E; Auer, M; Heitzer, E; Ulz, P; Birner-Gruenberger, R; Liesinger, L; Lenihan-Geels, GN; Oster, M; Spreitzer, E; Zenezini, Chiozzi, R; Schulz, TJ; Schupp, M; Madl, T; Heck, AJR; Prokesch, A
Complementary omics strategies to dissect p53 signaling networks under nutrient stress.
Cell Mol Life Sci. 2022; 79(6):326
Doi: 10.1007/s00018-022-04345-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klymiuk, I; Bilgilier, C; Mahnert, A; Prokesch, A; Heininger, C; Brandl, I; Sahbegovic, H; Singer, C; Fuereder, T; Steininger, C
Chemotherapy-associated oral microbiome changes in breast cancer patients.
Front Oncol. 2022; 12:949071
Doi: 10.3389/fonc.2022.949071
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Honeder, S; Tomin, T; Nebel, L; Gindlhuber, J; Fritz-Wallace, K; Schinagl, M; Heininger, C; Schittmayer, M; Ghaffari-Tabrizi-Wizsy, N; Birner-Gruenberger, R
Adipose Triglyceride Lipase Loss Promotes a Metabolic Switch in A549 Non-Small Cell Lung Cancer Cell Spheroids.
Mol Cell Proteomics. 2021; 20:100095
Doi: 10.1016/j.mcpro.2021.100095
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomin, T; Schittmayer, M; Honeder, S; Heininger, C; Birner-Gruenberger, R
Irreversible oxidative post-translational modifications in heart disease.
Expert Rev Proteomics. 2019; 16(8):681-693
Doi: 10.1080/14789450.2019.1645602
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG